C

    Corbus Pharmaceuticals Holding (CRBP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.91
    +0.00 (+0.00%)

    Market Cap: $211.01M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(17/40)
    Avg Surprise
    -4.71%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.21
    Range$-1.91 - $-0.73
    10 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-1.02+16.0%
    60d ago$-1.03+14.8%
    30d ago$-1.03+14.8%
    7d ago$-1.03+14.8%
    Current$-1.21
    Revenue Consensus
    $1M
    Range$0 - $10M
    9 analysts
    Dec 31, 2026
    EPS Consensus$-1.76
    Range$-3.14 - $-0.39
    10 analysts
    Revenue Consensus
    $0
    Range$-1111110 - $9M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.76---
    Sep 26EST
    		-$-1.21---
    Jun 26
    		$-1.81$-1.30-39.23%Miss-25.7%
    Mar 26
    		$-1.23$-1.22-0.82%Miss+11.5%
    Dec 25
    		$-1.25$-1.58+20.69%Beat-60.3%
    Sep 25
    		$-1.90$-1.71-11.11%Miss-65.2%
    Jun 25
    		$-1.44$-1.33-8.27%Miss-60.0%
    Mar 25
    		$-1.39$-1.07-29.91%Miss-67.5%
    Dec 24
    		$-0.78$-1.26+38.04%Beat+56.9%
    Sep 24
    		$-1.15$-0.95-21.05%Miss+49.3%
    Jun 24
    		$-0.90$-1.19+24.37%Beat+56.1%
    Mar 24
    		$-0.83$-1.09+23.85%Beat+80.4%
    Dec 23
    		$-1.81$-2.36+23.31%Beat+30.7%
    Sep 23
    		$-2.27$-2.06-10.19%Miss-8.1%
    Jun 23
    		$-2.05$-3.10+33.87%Beat+37.9%
    Mar 23
    		$-4.24$-4.09-3.67%Miss-76.7%
    Dec 22
    		$-2.61$-2.10-24.29%Miss-8.8%
    Sep 22
    		$-2.10$-1.65-27.27%Miss-250.0%
    Jun 22
    		$-3.30$-1.80-83.33%Miss+26.7%
    Mar 22
    		$-2.40$-2.55+5.88%Beat+42.9%
    Dec 21
    		$-2.40$-3.22+25.47%Beat+20.0%
    Sep 21
    		$-0.60N/A+81.82%Beat+95.3%
    Jun 21
    		$-4.50$-3.75-20.00%Miss+71.2%
    Mar 21
    		$-4.20$-4.80+12.50%Beat+67.4%
    Dec 20
    		$-3.00N/A+60.32%Beat+75.6%
    Sep 20
    		$-12.90$-12.18-5.91%Miss-34.4%
    Jun 20
    		$-15.60$-11.25-38.67%Miss-1833.3%
    Mar 20
    		$-12.90$-12.70-1.57%Miss+0.0%
    Dec 19
    		$-12.30$-10.74-14.53%Miss-36.7%
    Sep 19
    		$-9.60$-10.90+11.93%Beat-23.1%
    Jun 19
    		$0.90N/A+108.43%Beat+114.3%
    Mar 19
    		$-12.90$-4.45-189.89%Miss-104.8%
    Dec 18
    		$-9.00$-7.80-15.38%Miss-42.9%
    Sep 18
    		$-7.80$-6.65-17.29%Miss-85.7%
    Jun 18
    		$-6.30$-6.45+2.33%Beat-40.0%
    Mar 18
    		$-6.30$-4.10-53.66%Miss-31.3%
    Dec 17
    		$-6.30$-4.62-36.36%Miss-16.7%
    Sep 17
    		$-4.20$-4.80+12.50%Beat-16.7%
    Jun 17
    		$-4.50$-5.60+19.64%Beat-
    Mar 17
    		$-4.80$-4.80+0.00%Beat-
    Dec 16
    		$-5.40$-4.10-31.71%Miss-
    Sep 16
    		$-3.60$-3.30-9.09%Miss-

    Key Metrics

    Valuation
    P/E Ratio-1.76EV/EBITDA0.17x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-95.60%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio5.71xQuick Ratio5.71x
    Trading Statistics
    Beta2.62Avg Volume495.51K
    52-Week High$20.5652-Week Low$7.12

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.65
    SMA 20$10.24
    SMA 50$9.50
    SMA 200$9.28
    EMA 10$10.72
    EMA 20$10.32
    EMA 50$9.75
    EMA 200$9.46

    MACD

    Line: 0.48Signal: 0.41Hist: 0.07

    ADX

    ADX: 30.2+DI: 26.3-DI: 15.7

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down16.0
    PSAR$10.05

    Bollinger Bands

    Upper Band$11.48
    Lower Band$9.00
    %B Position2425%(Upper)
    Band Width0.77

    RSI (14-Day)

    Neutral
    62.7

    Momentum Oscillators

    Stoch %K73.9
    Stoch %D81.1
    Williams %R-29.6
    ROC (10d)4.0%
    Momentum0.42
    CCI (20d)77.1
    MFI (14d)72.0

    Volatility Measures

    ATR (14d)$0.57(5.2%)
    StdDev (20d)0.62
    Hist Vol53.0%(High)

    Volume Flow

    VWAP$10.76
    OBV-1.8M
    AD Line-3.6M
    CMF (20d)0.286

    Volume Metrics

    Avg Vol (20d)513.7K
    Vol Ratio0.9x
    VWMA (20d)$10.43

    Pivot Points

    R3$11.76
    R2$11.53
    R1$11.22
    Pivot Point$10.98
    S1$10.67
    S2$10.44
    S3$10.13

    Advanced Oscillators

    TSI27.31
    Ultimate Osc66.0
    KST146.18

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.16M$1.40M$1.41M$1.13M$1.31M$1.68M$4.71M$0$1.60M$0$1.64M$0
    Cost of Revenue$0$0$49,000$0$0$0$146,000$0$0$0$147,978$0
    Gross Profit$1.16M$1.40M$1.41M$1.13M$1.31M$1.68M$4.71M$0$1.60M$0$1.64M$0
    Operating Expenses$36.19M$48.61M$43.93M$48.83M$19.15M$39.55M$50.34M$15.51M$21.98M$9.62M$20.21M$18.98M
    R&D$31.18M$19.82M$18.41M$20.86M$15.19M$15.64M$8.79M$10.81M$6.87M$5.76M$6.98M$6.55M
    SG&A$5.01M$4.49M$3.56M$3.56M$3.96M$4.13M$3.82M$4.70M$4.12M$3.86M$3.12M$2.94M
    Operating Income$-36,190,000$-24,304,000$-21,966,000$-24,417,000$-19,152,000$-19,775,000$-12,605,000$-15,505,000$-10,988,000$-9,623,000$-10,103,975$-9,488,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$19.19M$0$0$0$24.11M$381,000$652,000$839,000$1.64M$763,000
    Income Before Tax$-35,037,000$-46,046,000$-41,160,000$-46,648,000$-17,662,000$-34,014,000$-36,716,000$-15,686,000$-20,053,000$-7,927,000$-16,037,999$-20,090,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-35,037,000$-45,938,000$-41,110,000$-46,684,000$-17,662,000$-33,956,000$-19,060,000$-27,566,000$-19,994,000$-13,798,000$-16,044,376$-20,106,000
    EBITDA$-36,376,000$-23,441,000$-21,247,000$-23,356,000$-19,343,000$-16,043,000$-4,387,000$-15,710,000$-10,689,000$-7,657,000$-5,671,046$-9,629,000
    EBIT$-36,201,000$-23,144,000$-20,604,000$-23,356,000$-18,976,000$-15,920,000$-3,694,000$-15,305,000$-10,013,000$-7,088,000$-5,929,046$-9,839,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRBP

    News

    Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day

    Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rose 2.99% to $10.69 on Monday, outperforming the mixed market session. This marked the stock's second consecutive day of gains. The Dow Jones Industrial Average saw a slight increase, while the NASDAQ Composite Index experienced a decrease.

    MarketWatch•8/24/26•
    Bullish

    CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst

    Corbus Pharmaceuticals Holdings (CRBP) has initiated a Phase 3 study for its drug CRB-701, aimed at treating previously treated oropharyngeal squamous cell carcinoma. The study will evaluate CRB-701 against standard therapies, focusing on tumor shrinkage and safety. This trial represents a significant catalyst for CRBP, with investors closely monitoring its progress.

    The Globe and Mail•8/22/26•
    Bullish

    Corbus Pharmaceuticals Holdings, Inc. Revenue Breakdown – NASDAQ:CRBP

    The article provides a title for "Corbus Pharmaceuticals Holdings, Inc. Revenue Breakdown" with its NASDAQ ticker CRBP. It appears to be an introductory or placeholder page from TradingView, focusing on accessing financial data for the company rather than presenting the breakdown itself. The content highlights where to find financial statements, statistics, dividends, earnings, and segment information on the TradingView platform.

    TradingView•8/22/26•
    Neutral

    Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day

    Corbus Pharmaceuticals Holdings Inc. (CRBP) saw its stock rise by 5.49% to $10.38 on Friday, outperforming the broader market. This gain snapped a three-day losing streak for the company. The NASDAQ Composite Index and the Dow Jones Industrial Average also experienced gains during the trading session.

    MarketWatch•8/21/26•
    Bullish

    Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day

    Corbus Pharmaceuticals Holdings Inc. (CRBP) saw its stock slip by 1.50% to $9.84, marking its third consecutive day of losses. This occurred during a challenging trading session where both the NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines. Despite these losses, the article headline suggests the stock still outperformed its competitors.

    MarketWatch•8/20/26•
    Neutral

    Frequently Asked Questions About CRBP

    Does CRBP pay dividends?
    Corbus Pharmaceuticals Holding (CRBP) does not currently pay a regular dividend.
    What is CRBP's market cap?
    Corbus Pharmaceuticals Holding (CRBP) has a market capitalization of $211.01M with a current stock price of $10.91.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In